| Drug Name: | Raltegravir (518048-05-0) |
|---|---|
| PubChem ID: | 54671008 |
| SMILES: | CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F |
| InchiKey: | CZFFBEXEKNGXKS-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 444.423 |
| LogP | : | 0.91152 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 9 |
| Hydrogen Bond Donor Count | : | 3 |
| Total Polar Surface Area | : | 152.24 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category